Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets

被引:16
|
作者
He, Jiangnan
Siu, Michelle K. Y.
Ngan, Hextan Y. S.
Chan, Karen K. L. [1 ]
机构
[1] Univ Hong Kong, Li Ka Shing LKS Fac Med, Dept Obstet, Pok Fu Lam, Hong Kong, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词
cholesterol metabolism; tumor microenvironment; carcinogenesis; therapeutic targets; ovarian cancer; SQUALENE EPOXIDASE; POOR-PROGNOSIS; CELL-DEATH; T-CELLS; RECEPTOR; ACTIVATION; INHIBITION; PROMOTES; OXYSTEROLS; EXPRESSION;
D O I
10.3389/fonc.2021.738177
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cholesterol is an essential substance in mammalian cells, and cholesterol metabolism plays crucial roles in multiple biological functions. Dysregulated cholesterol metabolism is a metabolic hallmark in several cancers, beyond the Warburg effect. Reprogrammed cholesterol metabolism has been reported to enhance tumorigenesis, metastasis and chemoresistance in multiple cancer types, including ovarian cancer. Ovarian cancer is one of the most aggressive malignancies worldwide. Alterations in metabolic pathways are characteristic features of ovarian cancer; however, the specific role of cholesterol metabolism remains to be established. In this report, we provide an overview of the key proteins involved in cholesterol metabolism in ovarian cancer, including the rate-limiting enzymes in cholesterol biosynthesis, and the proteins involved in cholesterol uptake, storage and trafficking. Also, we review the roles of cholesterol and its derivatives in ovarian cancer and the tumor microenvironment, and discuss promising related therapeutic targets for ovarian cancer.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Aberrant phosphatidylcholine metabolism as source of biomarkers and therapeutic targets in human ovarian cancer
    Iorio, E.
    Ricci, A.
    Pisanu, M. E.
    Bagnoli, M.
    de Cecco, L.
    Mezzanzanica, D.
    Canese, R.
    Spadaro, F.
    Canevari, S.
    Podo, F.
    EJC SUPPLEMENTS, 2010, 8 (05): : 96 - 97
  • [2] Potential Therapeutic Targets in Ovarian Cancer: Autophagy and Metabolism
    Park, Misung
    Choe, Soohyun
    Shin, Miyoung
    Kim, Ayoung
    Mo, Kyumin
    Kwon, Hyeonseok
    Yoon, Hyunho
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (03):
  • [3] Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer
    Pyragius, Carmen E.
    Fuller, Maria
    Ricciardelli, Carmela
    Oehler, Martin K.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (04): : 7742 - 7756
  • [4] Identification of therapeutic targets applicable to clinical strategies in ovarian cancer
    Kim, Marianne K.
    Caplen, Natasha
    Chakka, Sirisha
    Hernandez, Lidia
    House, Carrie
    Pongas, Georgios
    Jordan, Elizabeth
    Annunziata, Christina M.
    BMC CANCER, 2016, 16
  • [5] Identification of therapeutic targets applicable to clinical strategies in ovarian cancer
    Marianne K. Kim
    Natasha Caplen
    Sirisha Chakka
    Lidia Hernandez
    Carrie House
    Georgios Pongas
    Elizabeth Jordan
    Christina M. Annunziata
    BMC Cancer, 16
  • [6] Identification of novel targets for ovarian cancer treatment.
    Noriega, Ricardo
    Reyes, Jeyshka
    Quinones, Blanca
    Serrano, Joseline
    Vivas, Pablo
    Perez, Josue
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 68 - 68
  • [7] Identification of novel therapeutic targets to overcome chemoresistance in high-grade serous ovarian cancer
    Christie, E.
    Huang, C.
    Zhang, V.
    Cowley, K.
    Simpson, K.
    Wang, G.
    Cao, P.
    Wiedemeyer, W.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S113 - S113
  • [8] Role of lncRNAs as Novel Biomarkers and Therapeutic Targets in Ovarian Cancer
    Fu, Lu-lu
    Li, Chun-jin
    Xu, Ying
    Li, Ling-yun
    Zhou, Xu
    Li, Dan-dan
    Chen, Shu-xiong
    Wang, Feng-ge
    Zhang, Xue-ying
    Zheng, Lian-wen
    CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 2017, 27 (02): : 183 - 195
  • [9] Aberrant Energy Metabolism in Tumors and Potential Therapeutic Targets
    Fan, Shuhao
    Guo, Jianhua
    Nie, Hui
    Xiong, Huabao
    Xia, Yong
    GENES CHROMOSOMES & CANCER, 2024, 63 (11):
  • [10] Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers
    Stany, Michael P.
    Vathipadiekal, Vinod
    Ozbun, Laurent
    Stone, Rebecca L.
    Mok, Samuel C.
    Xue, Hui
    Kagami, Takashi
    Wang, Yuwei
    McAlpine, Jessica N.
    Bowtell, David
    Gout, Peter W.
    Miller, Dianne M.
    Gilks, C. Blake
    Huntsman, David G.
    Ellard, Susan L.
    Wang, Yu-Zhuo
    Vivas-Mejia, Pablo
    Lopez-Berestein, Gabriel
    Sood, Anil K.
    Birrer, Michael J.
    PLOS ONE, 2011, 6 (07):